Podcast:Considerations in ophthalmic formulation development for various ocular diseases

Considerations in Ophthalmic Formulation Development for Various Ocular Diseases

Sponsored By

For more than 10 years, Dow has been intimately involved in ophthalmic formulation development for various ocular diseases such as cataract, ocular hyphema, dry-eye, age-related macular degeneration, glaucoma, etc. This podcast will attempt to share such ophthalmic formulation technology with the scientists and formulators who are interested in developing eye-care products.

WHITEPAPERS

• Considerations in Ophthalmic Formulation Development for Various Ocular Diseases
• Topical Dermatological Formulation Development – “Things You Should Know”